Highly Anticipated Weight Loss Product, Satietrol® ,
(PRWEB) April 6, 2000
Woodbridge, NJ, April 4, 2000 - Satietrol® , a highly anticipated product developed by PacificHealth Laboratories, Inc. (NASDAQ: PHLI) and clinically proven to help people lose weight by activating the body’s natural appetite control mechanism, will be available on April 10, 2000.
Satietrol can be purchased by calling 1-877-SATIETY or through a website hungeroff. com. The product will be carried by a number of major Internet retailers and will be available at retail shortly. The suggested retail price for Satietrol is $39.99 for 42 servings.
The advertising campaign will break in all Philadelphia newspapers on April 10th. Philadelphia was recently ranked as “America’s Fattest City”. Following Philadelphia, the campaign will be extended to other major markets.
Satietrol is the first weight loss product designed to activate cholecystokinin (CCK). CCK is a protein released after a meal, which gives an individual a feeling of fullness or satiety. Satietrol activates CCK prior to a meal and extends the action of CCK after a meal. Clinical trials have shown that Satietrol:
· Decreased hunger up to 35% for as long as 3.5 hours after eating.
· Produced a mean weight loss of 9 lbs in a six-week home trial involving 115 subjects.
· Maintained and even enhanced its effect on appetite with continued use.
Twenty-five years ago, researchers showed that CCK is largely responsible for the feeling of fullness or satiety experienced after a meal. Although CCK appeared to offer great promise as a natural appetite control agent, its use for weight loss was limited by the fact that it only worked when given by injection.
Satietrol is an 80-calorie vanilla flavored beverage, which is consumed 10-15 minutes before each meal. To stimulate CCK release, Satietrol contains glycomacropeptide, a protein derived from milk, calcium and a small amount of fatty acids. To extend the action of CCK, Satietrol contains two soluble fibers, guar and glucomannan, as well as potato fiber, and plant saponins from alfalfa.
Satietrol is a culmination of four years of research by PacificHealth Laboratories, Inc. and represents their first entry into the $50 billion weight loss category. The company recently filed a patent on this product.
-- more --
SATIETROL LAUNCH
Page 2
According to Dr. Robert Portman, President and CEO, “Satietrol offers enormous promise to the 50% of adult Americans who are overweight. Because it works by stimulating the body’s natural satiety mechanisms, it does not cause the side effects generally associated with diet products. When used with dietary restriction, Satietrol can help an individual lose weight and reduce hunger cravings. Satietrol does not require a major change in diet behavior. Individuals will lose weight because they’ll feel full or satisfied with less food.”
For more information, call toll free 1-877-SATIETY or visit www. hungeroff. com. To arrange media interviews, contact Mark Beal or Fabiola Zanzo at 212-714-1280.
# # #
